BioWraptor raises $1.5M
BioWraptor announced a Pre-Seed round of $1.5M on 12 November 2026. The company operates in HealthTech and is based in United States. It was founded by Maeva Coste, Co-founder. Announced yesterday.
Founder
Maeva Coste
Co-founder, BioWraptor
LinkedIn not available
Outreach angles
- -Maeva Coste co-founded BioWraptor with Jen Laws.
- -BioWraptor stabilises fragile biomolecules at room temperature.
- -The $1.5M pre-seed comes from investors including Anima x Alpha Star, SNOCAP and NY Ventures.
Signals
Pre-SeedDeep TechHealthcare
Round details
Company: BioWraptor
Domain: biowraptor
Amount: $1.5M
Stage: Pre-Seed
Industry: HealthTech
Country: United States
Announced: 12 November 2026
Other HealthTech raises
Recently funded in United States